Article Text

Download PDFPDF

2022-RA-1662-ESGO Tumor induced stromal senescence in high grade serious ovarian cancer. A preclinical study on novel prognostic biomarkers and preliminary prospects on therapeutic potential
  1. Alessia Salamina1,
  2. Claudia Giglioni1,
  3. Virginia Noferi1,
  4. Ernesto Gallucci1,
  5. Irene Paterno’1,
  6. Flavia Sorbi2 and
  7. Elisa Farsi1
  1. 1Dipartimento Materno Infantile, Azienda Ospedaliero Universitaria Careggi, Firenze, Italy
  2. 2Department of Biomedical, Experimental and Clinical Sciences, Division of Obstetrics and Gynecology, University of Florence, Firenze, Italy


Introduction/Background Extensive cytoreductive surgery combined with chemotherapy is currently the standard treatment for high grade serous ovarian cancer (HGSOC). Yet, up to 80% of patients relapse, due to either platinum or PARP-inhibitor resistance. Recent preclinical data suggest that tumor-induced senescence (TIS) could play a pivotal role in chemo-resistance development. The primary endpoint of this study is to assess whether neoadjuvant chemotherapy (NACT) induces TIS and whether this phenotype can worsen the prognosis.

Methodology This is a retrospective cohort study conducted on HGSOC histologic specimens fixed in formalin and embedded in paraffin (FFPE), collected at Careggi University Hospital between May 2019 and January 202. Samples were collected during interval debulking surgery (group 1) or primary cytoreduction (group 2). Lipofuscin staining of stromal cells was used as immunohistochemistry (IHC) biomarker of TIS on FFPE samples. All FFPE’s results will be correlated with progression-free survival (PFS) using Cox proportional hazard regression. Univariate and multivariate analysis on clinical data of the two groups were performed.

Results Ten patients were enrolled in group 1 and nine in group 2. Lipofuscin staining was significantly more expressed in group 1 than in group 2 FFPE (50% vs 0%, p=0.0135). Univariate analysis showed that CA125 serum level at diagnosis was significantly higher in group 1 (p=0.0112), and PFS was longer in group 2 (p = 0.0012). At multivariate analysis, lipofuscin staining correlates with the CA 125 serum value at diagnosis (p = 0.041), PFS (p = 0.035) and relapse (p = 0.039).

Abstract 2022-RA-1662-ESGO Figure 1

Conclusion Our preliminary data demonstrate TIS development in HGSOC cells exposed to NACT, and this correlates with higher CA 125 at diagnosis, PFS and relapse. Further research on TIS in OC is needed to disclose its role in disease progression, and to identify suitable biomarkers for tailored treatment.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.